Literature DB >> 19729605

The phosphorylation motif at serine 225 governs the localization and function of sphingosine kinase 1 in resistance arteries.

Darcy Lidington1, Bernhard Friedrich Peter, Anja Meissner, Jeffrey T Kroetsch, Stuart M Pitson, Ulrich Pohl, Steffen-Sebastian Bolz.   

Abstract

OBJECTIVE: The purpose of this study was to characterize a phosphorylation motif at serine 225 as a molecular switch that regulates the pressure-dependent activation of sphingosine kinase 1 (Sk1) in resistance artery smooth muscle cells. METHODS AND
RESULTS: In isolated hamster gracilis muscle resistance arteries, pressure-dependent activation/translocation of Sk1 by ERK1/2 was critically dependent on its serine 225 phosphorylation site. Specifically, expression of Sk1(S225A) reduced resting and myogenic tone, resting Ca(2+), pressure-induced Ca(2+) elevations, and Ca(2+) sensitivity. The lack of function of the Sk1(S225A) mutant could not be entirely overcome by forced localization to the plasma membrane via a myristoylation/palmitylation motif; the membrane anchor also significantly inhibited the function of the wild-type Sk1 enzyme. In both cases, Ca(2+) sensitivity and myogenic tone were attenuated, whereas Ca(2+) handling was normalized/enhanced. These discrete effects are consistent with cell surface receptor-mediated effects (Ca(2+) sensitivity) and intracellular effects of S1P (Ca(2+) handling). Accordingly, S1P(2) receptor inhibition (1 micromol/L JTE013) attenuated myogenic tone without effect on Ca(2+).
CONCLUSIONS: Translocation and precise subcellular positioning of Sk1 is essential for full Sk1 function; and two distinct S1P pools, proposed to be intra- and extracellular, contribute to the maintenance of vascular tone.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19729605     DOI: 10.1161/ATVBAHA.109.194803

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  13 in total

1.  Inhibition of Sphingosine Kinase 1 Ameliorates Angiotensin II-Induced Hypertension and Inhibits Transmembrane Calcium Entry via Store-Operated Calcium Channel.

Authors:  Parker C Wilson; Wayne R Fitzgibbon; Sara M Garrett; Ayad A Jaffa; Louis M Luttrell; Michael W Brands; Hesham M El-Shewy
Journal:  Mol Endocrinol       Date:  2015-04-14

Review 2.  The emerging alliance of sphingosine-1-phosphate signalling and immune cells: from basic mechanisms to implications in hypertension.

Authors:  Nicholas Don-Doncow; Yun Zhang; Hana Matuskova; Anja Meissner
Journal:  Br J Pharmacol       Date:  2018-07-03       Impact factor: 8.739

Review 3.  Cerebral artery myogenic reactivity: The next frontier in developing effective interventions for subarachnoid hemorrhage.

Authors:  Darcy Lidington; Jeffrey T Kroetsch; Steffen-Sebastian Bolz
Journal:  J Cereb Blood Flow Metab       Date:  2017-11-14       Impact factor: 6.200

4.  Metoprolol impairs resistance artery function in mice.

Authors:  Mostafa H El Beheiry; Scott P Heximer; Julia Voigtlaender-Bolz; C David Mazer; Kim A Connelly; David F Wilson; W Scott Beattie; Albert K Y Tsui; Hangjun Zhang; Kabir Golam; Tina Hu; Elaine Liu; Darcy Lidington; Steffen-Sebastian Bolz; Gregory M T Hare
Journal:  J Appl Physiol (1985)       Date:  2011-07-28

5.  Tumor necrosis factor-α enhances microvascular tone and reduces blood flow in the cochlea via enhanced sphingosine-1-phosphate signaling.

Authors:  Elias Q Scherer; Jingli Yang; Martin Canis; Katrin Reimann; Karolina Ivanov; Christian D Diehl; Peter H Backx; W Gil Wier; Sebastian Strieth; Philine Wangemann; Julia Voigtlaender-Bolz; Darcy Lidington; Steffen-Sebastian Bolz
Journal:  Stroke       Date:  2010-10-07       Impact factor: 7.914

Review 6.  The TNF-α/sphingosine-1-phosphate signaling axis drives myogenic responsiveness in heart failure.

Authors:  Jeffrey T Kroetsch; Steffen-Sebastian Bolz
Journal:  J Vasc Res       Date:  2013-04-16       Impact factor: 1.934

7.  Sphingosine kinase isoforms as a therapeutic target in endocrine therapy resistant luminal and basal-A breast cancer.

Authors:  James W Antoon; Martin D White; Jennifer L Driver; Matthew E Burow; Barbara S Beckman
Journal:  Exp Biol Med (Maywood)       Date:  2012-08-02

8.  Selectivity and specificity of sphingosine-1-phosphate receptor ligands: caveats and critical thinking in characterizing receptor-mediated effects.

Authors:  Salvatore Salomone; Christian Waeber
Journal:  Front Pharmacol       Date:  2011-02-22       Impact factor: 5.810

9.  Arachnoid membrane as a source of sphingosine-1-phosphate that regulates mouse middle cerebral artery tone.

Authors:  Francesc Jiménez-Altayó; Julia Marzi; María Galan; Ana Paula Dantas; Marisa Ortega; Santiago Rojas; Gustavo Egea; Katja Schenke-Layland; Elena Jiménez-Xarrié; Anna M Planas
Journal:  J Cereb Blood Flow Metab       Date:  2021-09-02       Impact factor: 6.960

10.  Sphingosine-1-Phosphate Signaling Regulates Myogenic Responsiveness in Human Resistance Arteries.

Authors:  Sonya Hui; Andrew S Levy; Daniel L Slack; Marcus J Burnstein; Lee Errett; Daniel Bonneau; David Latter; Ori D Rotstein; Steffen-Sebastian Bolz; Darcy Lidington; Julia Voigtlaender-Bolz
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.